Immunotherapeutic strategies for cervical squamous carcinoma

Hematology/Oncology Clinics of North America

Volumn 13, Issue 1, 1999, Pages 259-273

  Van Driel, W J ^a   Kenter, G G ^a   Fleuren, G J ^a   Melief, C J M ^a   Trimbos, B J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; VIRUS VACCINE;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CONDYLOMA; FEMALE; GYNECOLOGIC CANCER; HUMAN; IMMUNOMODULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; UTERINE CERVIX CARCINOMA; VIRUS GENE; VIRUS TRANSMISSION; WART VIRUS;

EID: 0033003873     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0889-8588(05)70164-7     Document Type: Article

References (98)

1. P. Aichele K. Brouscha-Riem R.M. Zinkernagel T cell priming versus T cell tolerance induced by synthetic peptides J Exp Med 182 1995 261
2. S. Bagchi P. Raychaudhuri J.R. Nevins Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: A novel mechanism for E1A transactivation Cell 62 1990 659
3. C.J. Baker W.C. Phelps V. Lindgren Structural and transcriptional analysis of HPV 16 sequences in cervical carcinoma cell lines J Virol 61 1987 962
4. L.K. Borysiewicz A. Flander M. Nimako A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer Lancet 347 1996 1523
5. F.X. Bosch M.M. Manos N. Munoz Prevalence of human papillomavirus in cervical cancer: A worldwide perspective J Natl Canc Inst 87 1995 796
6. M.E.G. Boursnell E. Rutherford J.K. Hickling Construction and characterisation of a recombinant vaccinia virus expressing human papillomavirus proteins for immunotherapy of cervical cancer Vaccine 14 1996 1485
7. J.L. Brandsma Animal models of human-papillomavirus-associated oncogenesis Intervirology 37 1994 189
8. F. Breitburd R. Kirnbauer N.L. Hubbert Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection J Virol 69 1995 3959
9. C.M. Celluzi J.I. Mayordomo W.J. Storkus Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity J Exp Med 183 1996 283
10. L. Chen P. McGowen S. Ashe Tumor immunogenicity determines the effect of B7 costimulation of T cell–mediated tumor immunity J Exp Med 179 1994 523
11. N.D. Christensen C.A. Reed N.M. Cladel Immunization with virus-like particles induces long-term protection of rabbits against challenge with cottontail rabbit papillomavirus J Virol 70 1996 960
12. M.E. Connor P.L. Stern Loss of MHC class 1 expression in cervical carcinomas Int J Cancer 46 1990 1029
13. F.V. Cromme J. Airey Heemels M.-T. Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas J Exp Med 179 1994 335
14. F.V. Cromme C.J.L.M. Meijer P.J.F. Snijders Analysis of MHC class I and II expression in relation to presence of HPV genotypes in premalignant and malignant cervical lesions Br J Cancer 67 1993 1372
15. M.L.H. De Bruijn D.H. Schuurhuis M.P.M. Vierboom Immunization with human papillomavirus type 16 (HPV 16) oncoprotein-loaded, dendritic cells as well as protein in adjuvant induces MHC class I–restricted protection to HPV 16–induced tumor cells Cancer Res 58 1998 724
16. J.J. Donnelly D. Martinez K.U. Jansen Protection against papillomavirus with a polynucleotide vaccine J Infect Dis 731 1996 314
17. J.J. Donnelly B.U. Ulmer J.W. Shiver DNA vaccines Annu Rev Immunol 15 1997 617
18. J.J. Dowhanick A.A. McBride P.M. Howley Suppression of cellular proliferation by the papillomavirus E2 protein J Virol 69 1995 7791
19. J.R.M. Ellis P.J. Keating J. Baird The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer Nat Med 1 1995 464
20. D.E. Epperson D. Arnold T. Spies Cytokines increase transporter in antigen processing–1 expression more rapidly than HLA class I expression in endothelial cells J Immunol 149 1992 3297
21. E.M. Evans S. Man A.S. Evans Infiltration of cervical cancer tissue with human papillomavirus-specific cytotoxic T lymphocytes Cancer Res 57 1997 2943
22. M.V.W. Feltkamp H.L. Smits M.P.M. Vierboom Vaccination with cytotoxic T lymphocyte epitope–containing peptide protects against a tumor induced by human papillomavirus type 16–transformed cells Eur J Immuno 23 1993 2242
23. M.C.W. Feltkamp G.R. Vreugdenhil M.P.M. Vierboom CTL raised against a subdominant epitope offered as a synthetic peptide eradicate human papillomavirus type 16-induced tumors Eur J Immunol 25 1995 2638
24. L. Gao C. Sinclair L. Crawford Immune response to human papillomavirus type 16 E6 gene in a live vaccinia vector J Gen Virol 75 1994 157
25. F. Garrido T. Cabrera A. Concha Natural history of HLA expression during tumour development Immunol Today 14 1993 491
26. R.A. Gatti R.A. Good Occurrence of malignancies in immunodeficiency disease. A literate review Cancer 28 1971 89
27. D.J. Gillot A.M.E. Nouri S.J. Compton Accurate and rapid assessment of MHC antigen upregulation following cytokine stimulation J Immunol Methods 165 1993 231
28. H.L. Greenstone J.D. Nieland K.E. de Visser Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV 16 tumor model Proc Natl Acad Sci USA 95 1998 1800
29. M.E. Hagensee J.J. Carter G.C. Wipf Immunization of mice with HPV vaccinia virus recombinants generates serum IgG, IgM, and mucosal IgA antibodies Virology 206 1995 174
30. P.F. Halloran P. Autenried V. Ramassar Local T cell responses induce widespread MHC expression J Immunol 148 1992 3837
31. I. Hellstrom K.E. Hellstrom Third keystone symposium on cellular immunology and the immunotherapy of cancer Tumor vaccines–A reality at last? J Immunother 21 1998 119
32. R.A. Henderson H. Michel K. Sakaguchi HLA-A2.1–associated peptides from a mutant cell line: A second pathway of antigen presentation Science 255 1992 1264
33. C.G.J.M. Hilders J.G.A. Houbiers E.J.T. Krul The expression of histocompatibility-related leukocyte antigens in the pathway to cervical carcinoma Am J Clin Pathol 101 1994 5
34. C.G.J.M. Hilders J.G.A. Houbiers H.H. van Ravenswaay Claasen Association between HLA expression and infiltration of immune cells in cervical carcinoma Lab Invest 69 1993 651
35. C.G.J.M. Hilders L. Ras J.D.H. Van Eendenburg Isolation and characterization of tumor-infiltrating lymphocytes from cervical carcinoma Int J Cancer 57 1994 805
36. G.J.F. Ho R. Bierman L. Beardsley Natural history of cervicovaginal papillomavirus infection in young women N Engl J Med 338 1998 423
37. K.M. Hui P.T. Ang L. Huang Phase I study of immunotherapy of cutaneous metastases of human carcinoma using allogeneic and xenogeneic MHC DNA-liposome complexes Gene Ther 4 1997 783
38. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans: Human Papillomaviruses IARC Monographs on the Evaluation of Carcinogenic Risks to Humans vol. 14 1995 International Agency for Research on Cancer Lyons, France 64 (Geneva, World Health Organization)
39. K.U. Jansen M. Rosolowsky L.D. Schultz Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation Vaccine 13 1995 1509
40. F.D. Johnstone E. McGoogan G.E. Smart A population-based, controlled study of the relation between HIV infection and cervical neoplasia Br J Obstet Gynaecol 101 1994 986
41. W.M. Kast R. Offringa P.J. Peters Eradication of adenovirus E1–induced tumors by E1A-specific cytotoxic T lymphocytes Cell 59 1989 603
42. A.M. Kaufmann L. Gissmann C. Schreckenberger Cervical carcinoma cells transfected with the CD80 gene elicit a primary cytotoxic T lymphocyte response specific for HPV 16 E7 antigens Cancer Gene Ther 4 1997 377
43. P. Kaur J.K. McDougall Characterization of primary human keratinocytes transformed by human papillomavirus type 18 J Virol 62 1988 1917
44. P.J. Keating F.V. Cromme M. Duggan-Keen Frequency of down-regulation of individual HLA-A and B alleles in cervical carcinomas in relation to TAP-1 Br J Cancer 72 1995 405
45. G.G. Kenter C.J. Cornelisse M. Jiwa Human papillomavirus type 16 in tumor tissue of low stage squamous carcinoma of the uterine cervix in relation to ploidy grade and prognosis Cancer 71 1993 397
46. R. Kirnbaur F. Booy N. Cheng Papillomavirus L2 major capsid protein self-assembles into virus-like particles that are highly immunogenic Proc Natl Acad Sci USA 89 1992 12180
47. R. Kirnbauer N.L. Hubbert C. Wheeler A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16 J Natl Cancer Inst 86 1994 494
48. N.B. Kiviat L.A. Koutsky Specific human papillomavirus types as the causal agents of most cervical intraepithelial neoplasia: Implications for current views and treatment J Natl Cancer Inst 85 1993 934
49. L.A. Koopman A. Mulder W.E. Corver HLA class I phenotype and genotype alterations in cervical carcinomas and derivative cell lines Tissue Antigens 51 1998 623
50. V.K. Kuchroo M.P. Das J.A. Brown B7–1 and B7–2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy Cell 80 1995 707
51. T.D. Kuerbitz B.S. Plunkett W.V. Walsh Wild-type p53 is a cell cycle checkpoint determinant following irradiation Proc Natl Acad Sci USA 89 1992 7491
52. L.R. Livingstone A. White J. Sprouse Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53 Cell 70 1992 923
53. M. Londei J.R. Lamb G.F. Bottazzo Epithelial cells expressing aberrant MHC class II determinant can present antigen to cloned human T cells Nature 312 1984 639
54. L.P. Londono S. Chatfield R.W. Tindle Immunisation of mice using Salmonella typhimurium expressing human papillomavirus type 16 E7 epitopes inserted into hepatitis B virus core antigen Vaccine 14 1996 545
55. D.R. Lucey M. Clerici G.M. Shearer Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases Clin Microbiol Rev 9 1996 532
56. O. Mandelboim E. Vafai A. Katz-Hillel Regression of established murine carcinoma metastases following vaccination with tumour-associated antigen peptides Nat Med 1 1995 1179
57. J.I. Mayordomo T. Zorina W.J. Storkus Bone marrow–derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nat Med 1 1995 1297
58. C.A. Meanwell M.F. Cox G. Blackledge HPV 16 DNA in normal and malignant cervical epithelium: Implications for the aetiology and behaviour of cervical neoplasia Lancet 8535 1987 703
59. P.W.J. Melkert E. Hopman A.J.C. van den Brule Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent Int J Cancer 53 1993 919
60. T.R. Mosmann R.L. Coffman Two types of mouse helper T cell clone: Implications for immune regulation Immunol Today 8 1987 223
61. T.R. Mosmann S. Sad The expanding universe of T-cell subsets: Th1, Th2 and more Immunol Today 17 1996 138
62. J.J. Neefjes F. Momburg G.J. Hämmerling Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter Science 261 1993 769
63. M. Nimako A.N. Fiander G.W.G. Wilkinson HPV-specific CTLs in patients with cervical intraepithelial neoplasia grade III Cancer Res 57 1997 4855
64. P. Paglia C.A. Guzman Keeping the immune system alerted against cancer Cancer Immunol Immunother 46 1998 88
65. I. Penn Tumor incidence in human allograft recipients Transplant Proc 11 1979 1047
66. L. Pirisi S. Yasumoto M. Feller Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA J Virol 61 1987 1061
67. M.E. Ressing A. Sette R.M.P. Brandt Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A* 0201–binding peptides J Immunol 154 1995 5934
68. Ressing M.E. van Driel W.J. E. Celis Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16–positive cervical lesions against a human leukocyte antigen–A*0201–restricted E7-encoded epitope Cancer Res 56 1996 582
69. R.B.S. Roden N.L. Hubbert R. Kirnbauer F. Breitburd Papillomavirus L1 capsids agglutinate mouse erythrocytes through a proteinaceous receptor J Virol 69 1995 5147
70. R.B.S. Roden N.L. Hubbert R. Kirnbauer N.D. Christensen Assessment of the serological relatedness of genital human papillomavirus by hemagglutination inhibition J Virol 70 1996 3298
71. M. Scheffner B.A. Werness J.M. Huibregtse The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 Cell 63 1990 1129
72. M.H. Schiffman H.M. Bauer R.N. Hoover Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia J Natl Cancer Inst 85 1993 958
73. J.T. Schiller R.B.S. Boden Papillomavirus-like particles Papillomavirus Report 6 1995 121
74. J.T. Schiller D.R. Lowy Papillomavirus-like particles and HPV vaccine development Semin Cancer Biol 7 1996 373
75. V. Schneider S. Kay H.M. Lee Immunosuppression as a high-risk factor in the development of condyloma acuminatum and squamous neoplasia of the cervix Acta Cytol 27 1983 220
76. B. Seliger M.J. Maeurer S. Ferrone TAP off–Tumors on Immunol Today 18 1997 292
77. N. Shastri T. Serwold P. Paz Reading with the lines: Naturally processed peptides displayed by MHC class I molecules Curr Opin Immunol 10 1998 137
78. D. Smotkin F.O. Wettstein Transcription of HPV16 early genes in a cervical cancer and a cervical cancer derived cell line, and the identification of the E7 protein Proc Natl Acad Sci USA 83 1986 4680
79. P.L. Stern Immunity to human papillomavirus–associated cervical neoplasia Adv Cancer Res 69 1996 175
80. A. Storey M. Thomas A. Kalita Role of a p53 polymorphism in the development of human papillomavirus–associated cancer Nature 393 1998 229
81. D. Street A.M. Kaufmann A. Vaughan Interferon-gamma enhances susceptibility of cervical cancer cells to lysis by tumor-specific cytotoxic T cells Gynecol Oncol 65 1997 265
82. X.W. Sun L. Juhn T.V. Ellerbrock Human papillomavirus infection in women infected with the human immunodeficiency virus N Engl J Med 337 1997 1343
83. P. Sundaram R.E. Tigelaar W. Xiao Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge Vaccine 16 1998 613
84. K. Tamada M. Harada K. Abe Antitumor vaccination effect of dendritic cells can be augmented by locally utilizing Th1-type cytokines from OK432-reactive CD4+ T cells Cancer Immunol Immunother 46 1998 128
85. R. Tindle K. Herd L.P. Londono Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice Virology 200 1994 547
86. R.W. Tindle S. Croft K. Herd A vaccine conjugate of “ISCAR” immunocarrier and peptide epitopes of the E7 cervical cancer–associated protein of human papillomavirus type 16 elicits specific Th1- and Th2-type responses in immunized mice in the absence of oil-based adjuvants Clin Exp Immunol 101 1995 265
87. R.E.M. Toes R.J.J. Blom R. Offringa Enhanced tumor outgrowth after peptide vaccination: Functional deletion of tumor-specific CTL induced by peptide vaccination can lead to the inability to reject tumors J Immunol 156 1996 3911
88. R.E.M. Toes R. Offringa R.J.J. Blom R.M.P. Brandt An adenovirus type 5 early region 1B-encoded CTL epitope–mediating tumor eradication by CTL clones is downmodulated by an activated ras oncogene J Immunol 154 1995 3396
89. R.E.M. Toes R. Offringa R.J.J. Blom C.J.M. Melief Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction Proc Natl Acad Sci USA 93 1996 7855
90. S. Townsend J. Allison Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells Science 259 1993 368
91. G. Tweddel P. Heller M. Cunnane The correlation between HIV seropositivity, cervical neoplasia, and HPV subtypes 6/11, 16/18, 31/33/35 Gynecol Oncol 52 1994 161
92. J.B. Ulmer J.J. Donnelly S.E. Parker Heterologous protection against influenza by injection of DNA encoding a viral protein Science 259 1993 1745
93. J.B. Ulmer J.J. Donnelly S.E. Parker Heterologous protection against influenza by injection of DNA encoding a viral protein Science 1993 259 1745
94. W.J. van Driel M.Y. Tjiong C.G.J.M. Hilders Association of allele-specific HLA expression and histopathologic progression of cervical carcinoma Gynecol Oncol 62 1996 33
95. E.M. Villiers Heterogeneity of the human papillomavirus group J Virol 63 1989 4898
96. B. Vogelstein R.W. Kinzler P53 function and dysfunction Cell 70 1992 523
97. R.A. Weinberg Tumor suppressor genes Science 254 1991 1138
98. J.R. Yannelli C. Hyatt S. McConnell Growth of tumor-infiltrating lymphocytes from human solid cancers: Summary of a 5-year experience Int J Cancer 65 1996 413